Pura Pharmaceuticals Ltd in London, W12 8LE

Description

Data updated on: 01-11-2023

Pura Pharmaceuticals started its business in 2003 as a Private Limited Company under the ID 04878702. This particular business has been operating for twenty one years and it's currently active. The company's headquarters is located in London at 32 (basement). Anyone can also locate the company by the postal code : W12 8LE. The company's Standard Industrial Classification Code is 46460 and has the NACE code: Wholesale of pharmaceutical goods. 2022/03/31 is the last time when the company accounts were filed.

The corporation's trademark is "AvicennaPharmacy". They applied for its registration on Sat, 22nd Mar 2014 and it was printed in the journal number 2014-017.

With regards to this particular company, just about all of director's obligations have so far been done by Mohammad A. who was chosen to lead the company ten years ago. Since 2011 Salma P., had been functioning as a director for the company up until the resignation seven years ago. In addition a different director, including Mohammad A. resigned in October 2011.

Trade marks

Trademark UK00003048082

Trademark UK00003048082

Trademark image:	-
Trademark name:	AvicennaPharmacy
Status:	Application Published
Filing date:	2014-03-22
Owner name:	Pura Pharmaceuticals Ltd
Owner address:	AvicennaPharmacy, 41 Stroud Green Road, LONDON, United Kingdom, N4 3EF

Financial data based on annual reports

Profit & Loss
Date of Accounts	2012-03-31	2013-03-31	2014-03-31	2015-03-31	2016-03-31	2017-03-31
Currency
Net Worth	11 530	4 104	11 761	15 388	-34	10 521

Balance Sheet
Cash Bank In Hand	49 400	16 899	15 093	142	160
Current Assets	49 400	44 662	64 467	63 054	48 290	48 970
Debtors		12 653	25 264	31 116	16 129
Intangible Fixed Assets		105 000	105 000	84 000	73 500	63 000
Net Assets Liabilities Including Pension Asset Liability	11 530	4 104	1 761	15 388	-34	10 521
Stocks Inventory		15 110	24 110	35 786	32 000
Tangible Fixed Assets	1	24 576	24 392	23 202	21 190	18 988

Capital & Reserves
Called Up Share Capital	100	100	100	100	100	100
Profit Loss Account Reserve	11 430	4 004	11 661	-6 844	-134	10 421
Shareholder Funds	11 530	4 104	11 761	15 388	-34	10 521

Other Financial Data
Creditors Due After One Year	29 487	147 474	134 122	137 846	108 262	95 592
Creditors Due Within One Year	8 384	22 660	47 976	40 433	34 752	24 845
Fixed Assets	1	129 576	129 392	128 202	94 690	81 988
Intangible Fixed Assets Additions		105 000
Intangible Fixed Assets Aggregate Amortisation Impairment				21 000	31 500	42 000
Intangible Fixed Assets Amortisation Charged In Period					10 500	10 500
Intangible Fixed Assets Cost Or Valuation		105 000	105 000	105 000	105 000	105 000
Net Current Assets Liabilities	41 016	22 002	13 491	25 032	13 538	24 125
Number Shares Allotted		100	100	100	100	100
Par Value Share		1	1	1	1	1
Share Capital Allotted Called Up Paid	100	100	100	100	100	100
Tangible Fixed Assets Additions		25 000	3 300	1 423	875	511
Tangible Fixed Assets Cost Or Valuation	602	25 602	28 902	30 325	31 200	31 711
Tangible Fixed Assets Depreciation	601	1 026	4 510	7 123	10 010	12 723
Tangible Fixed Assets Depreciation Charged In Period		425	3 484	2 613	2 887	2 713
Total Assets Less Current Liabilities	41 017	151 578	145 883	153 234	108 228	106 113